av/sun-pharmaceutical--big.svg

COM:SUNPHARMA

Sun Pharmaceutical Industries Ltd.

  • Stock

Last Close

1,780.00

22/11 10:00

Market Cap

3.80T

Beta: -

Volume Today

1.42M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
average inventory
28.50B
-
43.95B
54.21%
60.46B
37.55%
66.28B
9.63%
68.57B
3.45%
73.83B
7.68%
78.80B
6.73%
84.36B
7.05%
89.97B
6.65%
97.55B
8.43%
average payables
13.42B
-
22.41B
66.94%
33.22B
48.22%
39.42B
18.69%
45.81B
16.19%
44.57B
2.70%
41.21B
7.54%
40.34B
2.11%
42.27B
4.78%
50.80B
20.20%
average receivables
37.14B
-
56.73B
52.76%
87.36B
54.00%
102.23B
17.03%
107.50B
5.15%
113.48B
5.57%
123.46B
8.79%
122.86B
0.48%
125.70B
2.31%
124.05B
1.31%
book value per share
89.44
-
106.61
19.19%
130.51
22.42%
152.45
16.82%
158.80
4.16%
172.59
8.68%
188.65
9.31%
193.65
2.65%
200.10
3.33%
233.27
16.58%
capex per share
-4.37
-
-9.84
124.89%
-14.06
42.88%
-15.37
9.32%
-8.17
46.81%
-13.39
63.85%
-6.43
52.00%
-4.88
24.12%
-6.23
27.77%
-8.69
39.44%
capex to depreciation
-2.21
-
-1.98
10.55%
-3.34
68.53%
-2.92
12.51%
-1.31
55.23%
-1.83
40.17%
-0.75
59.01%
-0.56
25.11%
-0.70
23.97%
-0.82
18.23%
capex to operating cash flow
-0.23
-
-0.44
94.27%
-0.50
12.40%
-0.52
4.35%
-0.50
3.76%
-1.46
191.47%
-0.24
83.92%
-0.19
19.39%
-0.17
12.25%
-0.42
152.72%
capex to revenue
-0.06
-
-0.09
53.16%
-0.12
40.67%
-0.12
0.95%
-0.08
38.90%
-0.11
48.88%
-0.05
57.41%
-0.04
25.98%
-0.04
10.19%
-0.05
23.86%
cash per share
46.30
-
54.54
17.80%
61.11
12.05%
63.87
4.53%
58.25
8.80%
46.59
20.02%
45.60
2.14%
39.86
12.58%
52.74
32.33%
66.27
25.64%
days of inventory on hand
337.48
-
266.06
21.16%
313.01
17.65%
264.62
15.46%
284.56
7.53%
311.56
9.49%
274.50
11.89%
332.20
21.02%
280.49
15.57%
359.90
28.31%
days payables outstanding
143.53
-
148.04
3.14%
170.04
14.86%
170.22
0.11%
197.11
15.80%
163.87
16.86%
142.70
12.92%
146.72
2.82%
139.65
4.82%
194.50
39.28%
days sales outstanding
81.36
-
104.05
27.89%
127.59
22.62%
130.85
2.56%
150.50
15.01%
152.04
1.03%
143.88
5.37%
130.31
9.43%
126.42
2.98%
97.00
23.27%
debt to assets
0.09
-
0.18
110.47%
0.16
14.26%
0.16
1.63%
0.16
0.88%
0.16
0.63%
0.12
25.04%
0.06
53.07%
0.02
67.67%
0.09
361.59%
debt to equity
0.14
-
0.35
153.86%
0.27
22.59%
0.27
1.33%
0.27
1.58%
0.25
6.85%
0.18
27.65%
0.08
54.67%
0.03
67.72%
0.12
357.82%
dividend yield
0.00
-
0.00
71.00%
0.00
190.06%
0.00
60.34%
0.01
351.53%
0.00
36.19%
0.02
290.40%
0.01
33.36%
0.01
9.53%
0.01
8.51%
earnings yield
0.03
-
0.02
30.15%
0.02
29.64%
0.04
76.20%
0.02
57.87%
0.02
30.78%
0.04
91.99%
0.02
64.24%
0.01
6.39%
0.04
140.80%
enterprise value
1.17T
-
2.48T
111.49%
1.98T
20.25%
1.67T
15.77%
1.24T
25.36%
1.18T
4.80%
871.67B
26.34%
1.41T
61.79%
2.16T
53.35%
2.38T
10.17%
enterprise value over ebitda
15.56
-
30.80
97.87%
22.91
25.62%
15.70
31.44%
20.18
28.53%
16.45
18.50%
11.60
29.50%
15.58
34.30%
18.64
19.68%
19.40
4.06%
ev to operating cash flow
29.61
-
46.59
57.34%
29.21
37.30%
23.52
19.49%
31.82
35.29%
53.88
69.35%
13.30
75.32%
22.86
71.87%
24.07
5.31%
48.04
99.59%
ev to sales
7.33
-
9.09
24.05%
7.13
21.54%
5.55
22.12%
4.77
14.11%
4.13
13.50%
2.70
34.64%
4.26
57.82%
5.63
32.25%
5.51
2.18%
free cash flow per share
14.74
-
12.29
16.62%
14.07
14.51%
14.10
0.20%
8.11
42.48%
-4.24
152.22%
20.89
593.20%
20.84
0.25%
31.21
49.78%
11.97
61.65%
free cash flow yield
0.03
-
0.01
53.20%
0.02
42.98%
0.02
19.40%
0.02
22.06%
-0.01
155.38%
0.06
770.36%
0.03
41.21%
0.03
2.12%
0.01
64.31%
graham net net
23.66
-
5.17
78.13%
26.83
418.55%
24.35
9.25%
13.17
45.92%
17.14
30.17%
22.11
29.01%
19.79
10.51%
35.02
76.94%
34.83
0.52%
graham number
174.71
-
212.78
21.79%
239.89
12.74%
315.28
31.43%
179.41
43.09%
207.70
15.76%
258.08
24.26%
203.69
21.08%
247.81
21.66%
430.44
73.69%
income quality
0.86
-
0.83
3.83%
1.00
20.39%
0.78
21.77%
1.12
43.48%
0.58
48.67%
1.31
126.98%
2.20
68.46%
2.00
9.04%
0.53
73.71%
intangibles to total assets
0.11
-
0.13
12.16%
0.16
27.80%
0.17
4.72%
0.17
1.68%
0.19
14.09%
0.19
1.12%
0.18
6.15%
0.18
2.05%
0.22
23.99%
interest coverage
301.48
-
37.92
87.42%
30.92
18.44%
25.88
16.31%
9.05
65.02%
9.00
0.63%
18.80
109.02%
49.43
162.90%
74.26
50.23%
56.70
23.65%
interest debt per share
12.49
-
38.20
205.97%
36.50
4.47%
42.28
15.86%
45.17
6.82%
46.01
1.87%
35.87
22.05%
16.71
53.41%
5.91
64.64%
29.42
397.89%
inventory turnover
1.08
-
1.37
26.84%
1.17
15.00%
1.38
18.29%
1.28
7.01%
1.17
8.66%
1.33
13.50%
1.10
17.37%
1.30
18.44%
1.01
22.06%
invested capital
0.14
-
0.35
153.86%
0.27
22.59%
0.27
1.33%
0.27
1.58%
0.25
6.85%
0.18
27.65%
0.08
54.67%
0.03
67.72%
0.12
357.82%
market cap
1.19T
-
2.46T
106.86%
1.97T
19.87%
1.65T
16.19%
1.22T
26.32%
1.15T
5.71%
845.29B
26.43%
1.43T
69.68%
2.19T
53.02%
2.36T
7.52%
net current asset value
97.62B
-
85.83B
12.07%
121.35B
41.38%
119.74B
1.33%
93.18B
22.18%
110.98B
19.10%
125.26B
12.87%
122.55B
2.17%
162.81B
32.85%
184.34B
13.22%
net debt to ebitda
-0.24
-
0.21
189.74%
0.05
77.17%
0.11
125.74%
0.40
262.39%
0.48
20.14%
0.35
26.85%
-0.27
175.65%
-0.28
4.45%
0.18
166.51%
net income per share
15.17
-
18.88
24.44%
19.60
3.83%
28.98
47.87%
9.01
68.91%
11.11
23.31%
15.69
41.25%
9.52
39.32%
13.64
43.25%
35.30
158.79%
operating cash flow per share
19.12
-
22.13
15.76%
28.13
27.12%
29.47
4.75%
16.28
44.74%
9.15
43.78%
27.32
198.42%
25.72
5.86%
37.45
45.61%
20.66
44.83%
payables turnover
2.54
-
2.47
3.04%
2.15
12.94%
2.14
0.11%
1.85
13.64%
2.23
20.28%
2.56
14.84%
2.49
2.74%
2.61
5.06%
1.88
28.20%
receivables turnover
4.49
-
3.51
21.81%
2.86
18.45%
2.79
2.50%
2.43
13.05%
2.40
1.02%
2.54
5.68%
2.80
10.41%
2.89
3.08%
3.76
30.33%
research and ddevelopement to revenue
return on tangible assets
0.12
-
0.11
12.07%
0.10
2.11%
0.14
31.59%
0.04
70.46%
0.05
26.12%
0.07
33.53%
0.04
39.65%
0.06
39.48%
0.14
136.28%
revenue per share
77.27
-
113.46
46.83%
115.25
1.57%
124.80
8.29%
108.64
12.95%
119.56
10.06%
134.73
12.68%
138.12
2.52%
160.15
15.95%
180.30
12.58%
roe
0.17
-
0.18
4.41%
0.15
15.19%
0.19
26.58%
0.06
70.15%
0.06
13.46%
0.08
29.22%
0.05
40.88%
0.07
38.63%
0.15
122.00%
roic
0.27
-
0.17
37.49%
0.16
5.16%
0.16
0.95%
0.06
59.99%
0.08
20.10%
0.08
10.76%
0.11
32.65%
0.14
28.85%
0.14
2.71%
sales general and administrative to revenue
0.04
-
0.06
68.71%
0.08
26.95%
0.06
27.25%
0.07
27.46%
0.06
16.52%
0.07
16.56%
0.07
4.42%
0.06
20.93%
shareholders equity per share
89.44
-
106.61
19.19%
130.51
22.42%
152.45
16.82%
158.80
4.16%
172.59
8.68%
188.65
9.31%
193.65
2.65%
200.10
3.33%
233.27
16.58%
stock based compensation to revenue
0.00
-
0.00
52.58%
0.00
69.77%
-0.00
103.56%
tangible asset value
171.27B
-
222.75B
30.06%
267.08B
19.90%
300.14B
12.38%
312.60B
4.15%
324.13B
3.69%
362.84B
11.94%
375.32B
3.44%
384.88B
2.55%
412.76B
7.24%
tangible book value per share
82.69
-
92.62
12.01%
110.99
19.83%
124.89
12.52%
130.29
4.33%
135.09
3.69%
151.22
11.94%
156.42
3.44%
160.41
2.55%
171.95
7.19%
working capital
126.97B
-
127.69B
0.57%
176.17B
37.97%
150.67B
14.48%
117.72B
21.87%
137.30B
16.63%
159.48B
16.16%
142.96B
10.35%
178.14B
24.61%
199.56B
12.02%

All numbers in (except ratios and percentages)